These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16395975)

  • 1. How much CT do we need for PEt/CT? A radiologist's perspective.
    Kuehl H; Antoch G
    Nuklearmedizin; 2005; 44 Suppl 1():S24-31. PubMed ID: 16395975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.
    Weber WA; Grosu AL; Czernin J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):160-70. PubMed ID: 18253106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
    Beyer T; Antoch G; Bockisch A; Stattaus J
    J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
    Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
    Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated PET/CT and cancer imaging.
    De Wever W; Coolen J; Verschakelen JA
    JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.
    Quarles van Ufford HM; Quekel LG; van Waes PF; de Haas PJ; de Klerk JM
    Hell J Nucl Med; 2007; 10(2):105-8. PubMed ID: 17684586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
    Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
    J Nucl Med Technol; 2010 Mar; 38(1):6-17. PubMed ID: 20197541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/computed tomography.
    Townsend DW
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography/computed tomography: protocol issues and options.
    Blodgett TM; McCook BM; Federle MP
    Semin Nucl Med; 2006 Apr; 36(2):157-68. PubMed ID: 16517237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET-CT in oncology: making the most of CT.
    Miles KA
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S87-93. PubMed ID: 18852084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning.
    Sattler B; Lee JA; Lonsdale M; Coche E
    Radiother Oncol; 2010 Sep; 96(3):288-97. PubMed ID: 20709416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
    Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
    J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
    Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
    J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
    Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT in prostate cancer: an unmet clinical need.
    Mintz A
    Oncology (Williston Park); 2014 Dec; 28(12):1065-6. PubMed ID: 25738198
    [No Abstract]   [Full Text] [Related]  

  • 17. How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting.
    Colleran GC; Kwatra N; Oberg L; Grant FD; Drubach L; Callahan MJ; MacDougall RD; Fahey FH; Voss SD
    Cancer Imaging; 2017 Nov; 17(1):28. PubMed ID: 29116015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
    Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
    J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast Media in PET/Computed Tomography Imaging.
    Dhull VS; Rana N; Nazar AH
    PET Clin; 2016 Jan; 11(1):85-94. PubMed ID: 26590446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging.
    Pfannenberg AC; Aschoff P; Brechtel K; Müller M; Klein M; Bares R; Claussen CD; Eschmann SM
    Br J Radiol; 2007 Jun; 80(954):437-45. PubMed ID: 17329683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.